Cardiovascular events in hospitalised patients with schizophrenia: a survival analysis

Ghina Al-Seddik1, Dory Hachem2, Chadia Haddad2

  • 1a Faculty of Sciences , Lebanese University , Beirut , Lebanon.

Insights

Schizophrenia patients face high cardiovascular event rates. The Atherosclerotic Cardiovascular Disease (ASCVD) score better predicts risk than the Framingham Risk Score (FRS) in this population.

Area of Science:

  • Cardiology
  • Psychiatry
  • Public Health

Background:

  • Individuals with schizophrenia exhibit elevated risks for cardiovascular diseases.
  • Traditional cardiovascular risk assessment tools may not fully capture risks in this population.

Purpose of the Study:

  • To assess cardiovascular event rates in hospitalized schizophrenia patients.
  • To compare the predictive performance of the Framingham Risk Score (FRS) and Atherosclerotic Cardiovascular Disease (ASCVD) scores for cardiovascular events.

Main Methods:

  • A cohort of 329 hospitalized schizophrenia patients was followed from January 1, 2013.
  • Cardiovascular events and mortality were meticulously recorded through patient file reviews.
  • The predictive accuracy of FRS and ASCVD scores was evaluated.

Main Results:

  • A total of 29 cardiovascular events occurred over a mean follow-up of 41.07 months.
  • The major composite outcome rate was 9.0 per 100 patient-years; secondary outcome rate was 7.2 per 100 patient-years.
  • ASCVD score significantly identified patients with reduced cardiovascular survival (RR=3.35, p=0.005), unlike FRS (p=0.078).

Conclusions:

  • The Atherosclerotic Cardiovascular Disease (ASCVD) score demonstrates superior predictive value for cardiovascular events in schizophrenia patients compared to the Framingham Risk Score (FRS).
  • Integrating ASCVD risk assessment into routine care for individuals with severe mental illness is recommended to mitigate cardiovascular risks.

Related Concept Videos

Introduction To Survival Analysis01:18

Introduction To Survival Analysis

Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
779
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
594
Truncation in Survival Analysis01:09

Truncation in Survival Analysis

Truncation in survival analysis refers to the exclusion of individuals or events from the dataset based on specific criteria related to the time of the event. This exclusion can happen in two primary forms: left truncation and right truncation.
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are...
616
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
421
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
756
Schizophrenia01:17

Schizophrenia

Schizophrenia, a term introduced by Swiss psychiatrist Eugen Bleuler in 1911, describes a severe psychological disorder marked by profound disruptions in attention, thought processes, language, emotion, and interpersonal relationships. The core feature of schizophrenia is psychosis — a state characterized by a fundamental detachment from reality. This disconnection manifests through distorted logic, impaired perception, and atypical behavior, severely affecting the lives of those...
934